Dr. Harris stated, "Such an award represents the work of many collaborators and research students and, in the case of the beta-alanine project also many years of unbroken research support from Natural Alternatives. I count myself very fortunate to have participated in two programs that have helped redefine sports nutrition. I am particularly indebted to the late Professor Eric Hultman of the Karolinska Institute, Stockholm, who died earlier this year, for early mentoring on creatine, and to Dr. John Wise of NAI for 15 years of research partnership."
Mark LeDoux, NAI CEO and Chairman said, "Dr. Harris' extensive study of beta-alanine and his many years of dedication to the field of sports nutrition is the foundation of NAI's comprehensive beta-alanine patent portfolio. We applaud Dr. Harris and his many academic achievements and look forward to many more years of successful partnership."
NAI's extensive beta-alanine patent portfolio covering various methods and compositions for increasing the anaerobic working capacity in tissues, includes six issued US patents and several pending US patent applications, as well as patents in Canada, Europe, Japan and China. NAI currently manufactures several nutritional supplements using beta-alanine for existing customers under its patent estate. NAI also has continued its support of beta-alanine clinical research, collaborating with renowned universities and physicians.
Professor Roger Harris was born in Coventry, Warwickshire, UK, in 1944 and gained a degree in biochemistry from the University of Wales, Aberystwyth, where he also undertook his Masters and PhD. Following eight years in Sweden in Professor Hultman's laboratory, Professor Harris spent a number of years in the UK pharmaceutical industry before returning to research once again in Sweden, then at the Animal Health Trust in the UK. From 1997 until his retirement from academic life in 2009, Professor Harris held the chair of Exercise Biochemistry and Sports Science at the University of Chichester, UK. Although now retired, he continues to collaborate with the Korean National Sport University, the Australian Institute of Sport, the University of Sao Paulo and Nottingham Trent University through his consultancy company, Junipa Ltd. Professor Harris has authored/co-authored over two hundred research papers as well as numerous book chapters.NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com. This press release contains forward-looking statements within the meaning of applicable securities laws that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our beta-alanine patent estate and the use of creatine and beta-alanine dietary supplements, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. The forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV